Current Gastroenterology Reports

, Volume 1, Issue 5, pp 449–454

The molecular genetics of colorectal cancer

  • Vincent W. Yang


Colorectal cancer is a major cause of morbidity and mortality among types of cancer in the United States. Significant progress has been made in understanding the molecular mechanisms that lead to it. Much knowledge was obtained through study of genetic changes that occur in individuals with a familial predisposition to colorectal cancer, including familial adenomatous polyposis (FAP) and hereditary nonpolyposis colorectal cancer (HNPCC) syndromes. The gene with mutations that result in FAP has been identified as adenomatous polyposis coli (APC). Similarly, mutations in several genes that normally function in DNA mismatch repair result in HNPCC. Colorectal cancer is the result of accumulated mutations in several additional oncogenes or tumor suppressor genes, and this information leads to the formulation of a genetic model for the disease. Recent studies have also identified a relatively prevalent polymorphism in the APC gene in Ashkenazi Jews that is associated with an increased risk for colorectal cancer. These studies present a paradigm based on the APC mutation (APC I1307K) for the screening of cancer susceptibility genes in the population at large. Currently available techniques for genetic testing of colorectal cancer are also discussed in this review, along with their ethical implications.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Landis SH, Murray T, Bolden S, et al.: Cancer statistics, 1998. CA Cancer J Clin 1998, 48:6–29.PubMedGoogle Scholar
  2. 2.
    American Cancer Society: Cancer Facts and Figures 1999. Atlanta, GA: American Cancer Society; 1999 ( Scholar
  3. 3.
    Parkin DM, Laara E, Muir CS: Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988, 41:184–197.PubMedCrossRefGoogle Scholar
  4. 4.
    Winawer SJ, Fletcher RH, Miller L, et al.: Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997, 112:594–642. This paper was prepared by a multidisciplinary expert panel that was commissioned by the US Agency for Health Care Policy and Research (AHCPR). It includes the most recent clinical guidelines for screening and surveillance of colorectal cancer.PubMedCrossRefGoogle Scholar
  5. 5.
    Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 1990, 61:759–767.PubMedCrossRefGoogle Scholar
  6. 6.
    Kinzler KW, Vogelstein B: Lessons from hereditary colorectal cancer. Cell 1996, 87:159–170. An in-depth review of the molecular genetics of colorectal cancer using information gathered from studying two hereditary colorectal cancer syndromes, FAP and HNPCC. The authors argue for a sequential genetic paradigm that eventually leads to the formation of colorectal neoplasia. Mechanistic explanations of the functions of the genes involved in hereditary CRC are presented.PubMedCrossRefGoogle Scholar
  7. 7.
    McKusick VA: Adenomatous Polyposis of the Colon; APC. In Online Mendelian Inheritance in Man. Edited by VA McKusick. Baltimore: The Johns Hopkins University; 1999:175100. ( Scholar
  8. 8.
    Herrera L, Kakati S, Gibas L, et al.: Gardner syndrome in a man with an interstitial deletion of 5q. Am J Med Genet 1986, 25:473–476.PubMedCrossRefGoogle Scholar
  9. 9.
    Bodmer WF, Bailey CJ, Bodmer J, et al.: Localization of the gene for familial adenomatous polyposis on chromosome Nature 1987, 328:614–616.PubMedCrossRefGoogle Scholar
  10. 10.
    Leppert M, Dobbs M, Scambler P, et al.: The gene for familial polyposis coli maps to the long arm of chromosome 5. Science 1987, 238:1411–1413.PubMedCrossRefGoogle Scholar
  11. 11.
    Kinzler KW, Nilbert MC, Su LK, et al.: Identification of FAP locus genes from chromosome 5q21. Science 1991, 253:661–665.PubMedCrossRefGoogle Scholar
  12. 12.
    Nishisho I, Nakamura Y, Miyoshi Y, et al.: Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 1991, 253:665–669.PubMedCrossRefGoogle Scholar
  13. 13.
    Groden J, Thliveris A, Samowitz W, et al.: Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991, 66:589–600.PubMedCrossRefGoogle Scholar
  14. 14.
    Joslyn G, Carlson M, Thliveris A, et al.: Identification of deletion mutations and three new genes at the familial polyposis locus. Cell 1991, 66:601–613.PubMedCrossRefGoogle Scholar
  15. 15.
    Ichii S, Horii A, Nakatsuru S, et al.: Inactivation of both APC alleles in an early stage of colon adenomas in a patient with familial adenomatous polyposis (FAP). Hum Mol Genet 1992, 1:387–390.PubMedCrossRefGoogle Scholar
  16. 16.
    Levy DB, Smith KJ, Beazer-Barclay Y, et al.: Inactivation of both APC alleles in human and mouse tumors. Cancer Res 1994, 54:5953–5958.PubMedGoogle Scholar
  17. 17.
    Knudson AG: Antioncogenes and human cancer. Proc Natl Acad Sci U S A 1993, 90:10914–10921.PubMedCrossRefGoogle Scholar
  18. 18.
    Miyoshi Y, Nagase H, Ando H, et al.: Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Hum Mol Genet 1992, 1:229–233.PubMedCrossRefGoogle Scholar
  19. 19.
    Powell SM, Zilz N, Beazer-Barclay Y, et al.: APC mutations occur early during colorectal tumorigenesis. Nature 1992, 359:235–237.PubMedCrossRefGoogle Scholar
  20. 20.
    Jen J, Powell SM, Papadopoulos N, et al.: Molecular determinants of dysplasia in colorectal lesions. Cancer Res 1994, 54:5523–5526.PubMedGoogle Scholar
  21. 21.
    Morin PJ, Vogelstein B, Kinzler KW: Apoptosis and APC in colorectal tumorigenesis. Proc Natl Acad Sci U S A 1996, 93:7950–7954.PubMedCrossRefGoogle Scholar
  22. 22.
    Su LK, Vogelstein B, Kinzler KW: Association of the APC tumor suppressor protein with catenins. Science 1993, 262:1734–1737.PubMedCrossRefGoogle Scholar
  23. 23.
    Morin PJ, Sparks AB, Korinek V, et al.: Activation of betacatenin-Tcf signaling in colon cancer by mutations in betacatenin or APC. Science 1997, 275:1787–1790. This paper defines the mechanism of action of the APC gene product. The authors indicate that mutations in this gene result in the activation of the b-catenin-Tcf-4 pathway. In addition, the authors report on their finding of activating mutations in the β-catenin gene in the absence of APC mutation in colorectal cancer cells.PubMedCrossRefGoogle Scholar
  24. 24.
    He TC, Sparks AB, Rago C, et al.: Identification of c-MYC as a target of the APC pathway. Science 1998, 281:1509–1512. Describes the identification of target genes in the signaling pathway of APC. The c-MYC oncogene was found to be one such target subjected to regulation by APC. Expression of c-MYC was found to be repressed by wild-type APC and activated by β-catenin, and these effects were mediated through Tcf-4 binding sites in the c-MYC promoter.PubMedCrossRefGoogle Scholar
  25. 25.
    McKusick VA: Colon Cancer, Familial Nonpolyposis. In Online Mendelian Inheritance in Man. Edited by VA McKusick. Baltimore: The Johns Hopkins University; 1999:120435–120436 ( Scholar
  26. 26.
    Ahlquist DA: Aggressive polyps in hereditary nonpolyposis colorectal cancer: targets for screening. Gastroenterology 1995, 108:1590–1592.PubMedCrossRefGoogle Scholar
  27. 27.
    Aaltonen LA, Peltomaki P, Leach FS, et al.: Clues to the pathogenesis of familial colorectal cancer. Science 1993, 260:812–816.PubMedCrossRefGoogle Scholar
  28. 28.
    Papadopoulos N, Lindblom A: Molecular basis of HNPCC: mutations of MMR genes. Hum Mutat 1997, 10:89–99. The authors review the molecular basis of HNPCC. Germline mutations in DNA mismatch repair genes in HNPCC kindreds are summarized. The implications for presymptomatic diagnosis are also discussed.PubMedCrossRefGoogle Scholar
  29. 29.
    Markowitz S, Wang J, Myeroff L, et al.: Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 1995, 268:1336–1338.PubMedCrossRefGoogle Scholar
  30. 30.
    Souza RF, Appel R, Yin J, et al.: Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours. Nat Genet 1996, 14:255–257.PubMedCrossRefGoogle Scholar
  31. 31.
    Rampino N, Yamamoto H, Ionov Y, et al.: Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997, 275:967–969.PubMedCrossRefGoogle Scholar
  32. 32.
    Yoshitaka T, Matsubara N, Ikeda M, et al.: Mutations of E2F-4 trinucleotide repeats in colorectal cancer with microsatellite instability. Biochem Biophys Res Commun 1996, 227:553–557.PubMedCrossRefGoogle Scholar
  33. 33.
    McKusick VA: Peutz-Jeghers Syndrome; PJS. In Online Mendelian Inheritance in Man. Edited by McKusick VA. Baltimore: The Johns Hopkins University; 1999:175200 ( Scholar
  34. 34.
    Hemminki A, Tomlinson I, Markie D, et al.: Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat. Genet. 1997, 15:87–90.PubMedCrossRefGoogle Scholar
  35. 35.
    Jenne DE, Reimann H, Nezu J, et al.: Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat. Genet. 1998, 18:38–43.PubMedCrossRefGoogle Scholar
  36. 36.
    McKusick VA: Juvenile Intestinal Polyposis. In Online Mendelian Inheritance in Man. Edited by McKusick VA. Baltimore: The Johns Hopkins University; 1999:174900 ( Scholar
  37. 37.
    Olschwang S, Serova-Sinilnikova OM, Lenoir GM, et al.: PTEN germ-line mutations in juvenile polyposis coli. Nat Genet 1998, 18:12–14.PubMedCrossRefGoogle Scholar
  38. 38.
    Howe JR, Roth S, Ringold JC, et al.: Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science 1998, 280:1086–1088.PubMedCrossRefGoogle Scholar
  39. 39.
    Kinzler KW, Vogelstein B: Landscaping the cancer terrain. Science 1998, 280:1036–1037. This brief review article summarizes the mechanisms of action of three types of genes that are causally related to CRC. The descriptive terms "gatekeeper", "caretaker," and "landscaper" are introduced.PubMedCrossRefGoogle Scholar
  40. 40.
    Bos JL, Fearon ER, Hamilton SR, et al.: Prevalence of ras gene mutations in human colorectal cancers. Nature 1987, 327:293–297.PubMedCrossRefGoogle Scholar
  41. 41.
    Cho KR, Oliner JD, Simons JW, et al.: The DCC gene: structural analysis and mutations in colorectal carcinomas. Genomics 1994, 19:525–531.PubMedCrossRefGoogle Scholar
  42. 42.
    MacGrogan D, Pegram M, Slamon D, et al.: Comparative mutational analysis of DPC4 (Smad4) in prostatic and colorectal carcinomas. Oncogene 1997, 15:1111–1114.PubMedCrossRefGoogle Scholar
  43. 43.
    Baker SJ, Fearon ER, Nigro JM, et al.: Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 1989, 244:217–221.PubMedCrossRefGoogle Scholar
  44. 44.
    Laken SJ, Petersen GM, Gruber SB, et al.: Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nat Genet 1997, 17:79–83. This is the original paper that described the presence of the I1307K mutation in the APC gene in Ashkenazi Jews. The relationship between this mutation and risk of CRC is examined, and the purported mechanism by which this missense mutation leads to a "hypermutable" state is discussed.PubMedCrossRefGoogle Scholar
  45. 45.
    Woodage T, King SM, Wacholder S, et al.: The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat Genet 1998, 20:62–65.PubMedCrossRefGoogle Scholar
  46. 46.
    Rozen P, Shomrat R, Strul H, et al.: Prevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer. Gastroenterology 1999, 116:54–57.PubMedCrossRefGoogle Scholar
  47. 47.
    Gruber SB, Petersen GM, Kinzler KW, et al.: Cancer, crash sites, and the new genetics of neoplasia. Gastroenterology 1999, 116:210–212.PubMedCrossRefGoogle Scholar
  48. 48.
    Powell SM, Petersen GM, Krush AJ, et al.: Molecular diagnosis of familial adenomatous polyposis. N Engl J Med 1993, 329:1982–1987.PubMedCrossRefGoogle Scholar
  49. 49.
    van der Luijt R, Khan PM, Vasen H, et al.: Rapid detection of translation-terminating mutations at the adenomatous polyposis coli (APC) gene by direct protein truncation test. Genomics 1994, 20:1–4.CrossRefGoogle Scholar
  50. 50.
    Luce MC, Marra G, Chauhan DP, et al.: In vitro transcription/ translation assay for the screening of hMLH1 and hMSH2 mutations in familial colon cancer. Gastroenterology 1995, 109:1368–1374.PubMedCrossRefGoogle Scholar
  51. 51.
    Korkko J, Annunen S, Pihlajamaa T, et al.: Conformation sensitive gel electrophoresis for simple and accurate detection of mutations: comparison with denaturing gradient gel electrophoresis and nucleotide sequencing. Proc Natl Acad Sci U S A 1998, 95:1681–1685.PubMedCrossRefGoogle Scholar
  52. 52.
    Giardiello FM, Brensinger JD, Petersen GM, et al.: The use and interpretation of commercial APC gene testing for familial adenomatous polyposis. N Engl J Med 1997, 336:823–827. This paper contains the result of a nationwide survey of physicians and genetic counselors on the use and interpretation of commercial APC gene testing for familial adenomatous polyposis. Survey results reveal that patients who underwent testing often received inadequate genetic counseling and that a significant fraction of the test results were misinterpreted by the physicians who ordered the tests.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 1999

Authors and Affiliations

  • Vincent W. Yang
    • 1
  1. 1.Division of Gastroenterology, Department of MedicineThe Johns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations